CROI 2010: Limb Fat & Bone Mineral Density

Bone and Limb Fat Outcomes of ACTG A5224s, a Substudy of ACTG A5202: A
Prospective, Randomized, Partially Blinded Phase III Trial of Abacavir/Lamivudine or TenofovirDF/Emtricitabine with Efavirenz or Atazanavir/Ritonavir for Initial Treatment of HIV-1 Infection.

Grace A McComsey, Case Western Reserve Univ, Cleveland, OH, US

No comments:

Post a Comment